Baker Avenue Asset Management, LP Royalty Pharma PLC Transaction History

Baker Avenue Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $1,706 - $2,039	65 Added 120.37%	119 $3,000
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $532 - $658	18 Added 50.0%	54 $1,000
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $65 - $78	-2 Reduced 5.26%	36 $1,000
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $1,488 - $1,673	38 New	38 $1,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.